{"product_id":"scripps-san-diego-genitourinary-annual-course-in-oncology-guaco-2025","title":"Scripps San Diego Genitourinary Annual Course in Oncology (GUACO) 2025","description":"\u003cdiv id=\"panel-70-0-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"1\"\u003e\r\n\u003cdiv class=\"native default panel-widget-style panel-widget-style-for-70-0-0-1\"\u003e\r\n\u003cdiv class=\"so-widget-sow-editor so-widget-sow-editor-base\"\u003e\r\n\u003cdiv class=\"siteorigin-widget-tinymce textwidget\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eScripps San Diego Genitourinary Annual Course in Oncology (GUACO) 2025\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 15 videos + 16 pdfs, size: 2.35 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: oncologists, urologists, radiation oncologists, advanced practice providers\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\r\nSAN DIEGO GU Annual Course in Oncology (GUACO) Presented by Scripps Cancer Center\r\n\r\nSeptember 12-13, 2025 Coronado Island Marriott • Coronado, California\r\n\r\nThe San Diego Genitourinary Annual Course in Oncology (GUACO) promises to be a premier event for clinicians and practitioners who care for patients suffering from genitourinary malignancies. The focus of this course will be on prostate, bladder, and kidney cancer. This dynamic course features expert-led sessions designed to provide attendees with an overview of standard-of-care treatment algorithms and options, as well as innovative strategies for patient care. Through interactive case-based discussions and engaging panel sessions, participants will have the opportunity to deepen their understanding of complex\r\nclinical scenarios and to translate knowledge into practice. Attendees will leave empowered with actionable tools and strategies to optimize patient outcomes, improve quality of life, and to elevate the standard of care for individuals suffering from GU malignancy.\r\n\r\n\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\r\n\r\nAfter attending this live activity, participants should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eSummarize the current landscape of prostate, bladder, and kidney cancer, highlighting epidemiological trends, advancements in diagnosis, treatment strategies, and ongoing challenges in patient management.\u003c\/li\u003e\r\n \t\u003cli\u003eExplore current best practices and emerging approaches in the management of localized and advanced genitourinary malignancies, focusing on evidence-based standards and innovative strategies shaping the future of GU cancer care.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop a comprehensive outline of optimal clinical approaches for utilizing available treatment modalities in the management of GU malignancy.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate multidisciplinary collaboration and shared decision-making into the management of complex patient cases, emphasizing coordinated care and proactive strategies to mitigate unfavorable clinical outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe Scripps San Diego \u003cem\u003eGenitourinary Annual Course in Oncology (GUACO) 2025\u003c\/em\u003e is best for oncologists, urologists, radiation oncologists, advanced practice providers, and trainees who want CME‑accredited, expert‑led updates on the latest therapies, clinical trials, and multidisciplinary management of genitourinary cancers.\r\n\u003ch3\u003e Who Should Attend\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eMedical oncologists and hematologists treating prostate, bladder, kidney, and testicular cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eUrologists and surgical oncologists involved in surgical management of GU malignancies.\u003c\/li\u003e\r\n \t\u003cli\u003eRadiation oncologists integrating systemic and local therapies for GU cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced practice providers (NPs, PAs, CNSs) working in oncology or urology clinics.\u003c\/li\u003e\r\n \t\u003cli\u003eResidents and fellows in oncology, urology, or radiation oncology preparing for subspecialty practice.\u003c\/li\u003e\r\n \t\u003cli\u003eOncology nurses and pharmacists supporting GU cancer treatment and survivorship care.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e What You’ll Learn\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eLatest clinical trial data and FDA approvals in GU oncology.\u003c\/li\u003e\r\n \t\u003cli\u003eUpdates in systemic therapies: immunotherapy, targeted therapy, and hormonal therapy for prostate and bladder cancer.\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical and radiation advances: minimally invasive techniques, focal therapy, and integration with systemic treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary case discussions: real‑world scenarios highlighting diagnostic and therapeutic challenges.\u003c\/li\u003e\r\n \t\u003cli\u003eSurvivorship and supportive care strategies tailored to GU cancer patients.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFriday, September 12, 2025\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e4 p.m. Registration \u0026amp; Welcome Reception\u003c\/li\u003e\r\n \t\u003cli\u003e5 p.m. Keynote Presentation New Frontiers in Molecular Imaging of Kidney Cancer Brian Shuch, MD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSaturday, September 13, 2025\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e7:30 a.m. Breakfast \u0026amp; View Exhibits\u003c\/li\u003e\r\n \t\u003cli\u003e8:25 a.m. Welcome \u0026amp; Educational Overview Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003eSession I: Prostate Cancer 8:30 a.m. Prostate Cancer Screening and Detection in 2025 Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:45 a.m. Role of Primary Therapy in Oligometastatic Prostate Cancer Shane Mesko, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9 a.m. Prostate Cancer Theranostics: Current and Future Nik Patel, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:15 a.m. Castrate Resistant Prostate Cancer in 2025 Mohammad Jaloudi, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:30 a.m. Case Presentations\/Panel Discussion 10 a.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\r\n \t\u003cli\u003eSession II: Bladder Cancer 10:30 a.m. Intravesical Therapy and Management of Non-Muscle Invasive Bladder Cancer Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003e10:45 a.m. Radiotherapy for Invasive Bladder Cancer: Review of Current Data Shane Mesko, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11 a.m. Role of Lymphadenectomy in 2025 Phil Kim, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:15 a.m. Immunotherapy and Antibody Drug Conjugates—Future of Systemic Therapy in Bladder Cancer Munveer Bhangoo, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:30 a.m. Case Presentations\/Panel Discussion Noon Lunch\u003c\/li\u003e\r\n \t\u003cli\u003eSession III: Kidney Cancer 1:15 p.m. Radiotherapy for Small Renal Masses Patrick Linson, MD\u003c\/li\u003e\r\n \t\u003cli\u003e1:30 p.m. Cytoreductive Nephrectomy in 2025 Carol Salem, MD\u003c\/li\u003e\r\n \t\u003cli\u003e1:45 p.m. Subtyping Renal Cell Carcinoma Phataraporn Thorson, MD\u003c\/li\u003e\r\n \t\u003cli\u003e2 p.m. Hereditary Kidney Cancer Guidelines 2025 Brian Shuch, MD\u003c\/li\u003e\r\n \t\u003cli\u003e2:15 p.m. Case Presentations\/Panel Discussion\u003c\/li\u003e\r\n \t\u003cli\u003e2:45 p.m. Adjourn Topics, times and speakers are subject to change\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954526490722,"sku":"MED-AMB05339","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Scripps-San-Diego-Genitourinary-Annual-Course-in-Oncology-GUACO-2025.jpg?v=1779378923","url":"https:\/\/meducourse.com\/products\/scripps-san-diego-genitourinary-annual-course-in-oncology-guaco-2025","provider":"Meducourse","version":"1.0","type":"link"}